LINC02605

Across TCGA pan-cancer cohorts, LINC02605 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02605 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC02605 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02605 expression acts as an unfavorable survival marker, although some lineages such as BRCA and COAD show a favorable association.

BRCA, COAD, and KIRP are the cancer types where LINC02605 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	All	0.603	0.459	<.001	112	view →
COAD	OS	Median	All	0.920	0.817	<.001	88	view →
KIRP	DFS	Tertile	All	0.783	0.948	<.001	81	view →
SKCM	DFS	Median	All	0.689	0.548	<.001	68	view →
KIRC	OS	Median	All	0.749	0.871	<.001	62	view →
LGG	DFS	Median	All	0.643	0.823	<.001	41	view →
UVM	DFS	Median	III,IV	0.207	0.674	.008	19	view →
THYM	OS	Tertile	All	0.702	0.964	.011	15	view →
ACC	DFS	Median	II,III,IV	0.187	0.667	.020	10	view →
READ	OS	Median	IV	0.788	0.418	.005	9	view →
LUAD	DFS	Median	IV	0.328	0.624	.013	8	view →
SARC	OS	Quartile	All	0.865	0.669	.002	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02605–BRCA (DFS)

Open the BRCA breakdown →